Pathways

Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study

Author(s): Larsen V; Kwan ML; Ergas IJ; Roh JM; Kushi LH; Yao S; et al.

Clin Breast Cancer. 2019 Mar 06.

PubMed abstract

Opportunities to Improve Detection and Treatment of Depression among Patients with Breast Cancer Treated in an Integrated Delivery System

Author(s): Check DK; Kwan ML; Chawla N; Dusetzina SB; Valice E; Ergas IJ; Roh JM; Kolevska T; Rosenstein DL; Kushi LH

J Pain Symptom Manage. 2018 Nov 30.

PubMed abstract

Understanding racial/ethnic differences in breast cancer-related physical well-being: the role of patient-provider interactions

Author(s): Check DK; Kwan ML; Roh JM; Ergas IJ; Kushi LH; et al.

Breast Cancer Res Treat. 2018 Apr 05.

PubMed abstract

Genetic Ancestry Is not Associated with Breast Cancer Recurrence or Survival in U.S. Latina Women Enrolled in the Kaiser Permanente Pathways Study

Author(s): Engmann NJ; Ergas IJ; Yao S; Kwan ML; Roh JM; Ambrosone CB; Kushi LH; Fejerman L

Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1466-1469.

PubMed abstract

Adiposity, post-diagnosis weight change, and risk of cardiovascular events among early-stage breast cancer survivors

Author(s): Cespedes Feliciano EM; Kwan ML; Kushi LH; Weltzien EK; Castillo AL; Caan BJ

Breast Cancer Res Treat. 2017 Feb 07.

PubMed abstract

Impact of social and built environment factors on body size among breast cancer survivors; the Pathways Study

Author(s): Shariff-Marco S; Von Behren J; Reynolds P; Keegan TH; Hertz A; Kwan ML; Roh JM; Thomsen C; Kroenke CH; Ambrosone CB; Kushi LH; Gomez SL

Cancer Epidemiol Biomarkers Prev. 2017 Feb 02.

PubMed abstract

BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients; The Pathways Study

Author(s): Greenlee H; Hershman DL; Shi Z; Kwan ML; Ergas IJ; Roh JM; Kushi LH

J Natl Cancer Inst. 2017 Feb 01;109(2):1-8.

PubMed abstract

Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis

Author(s): Yao S; Zhang Y; Tang L; Roh JM; Laurent CA; Hong CC; Hahn T; Lo JC; Ambrosone CB; Kushi LH; Kwan ML

Breast Cancer Res Treat. 2016 Dec 03.

PubMed abstract

Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early Stage Breast Cancer; The LACE and Pathways Studies

Author(s): Jones LW; Kwan ML; Weltzien EK; Chandarlapaty S; Sternfeld B; Sweeney C; Bernard PS; Castillo AL; Habel LA; Kroenke CH; Langholz BM; Quesenberry CP; Dang CT; Weigelt B; Kushi LH; Caan BJ

Cancer Res. 2016 Aug 3.

PubMed abstract

Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study

Author(s): Kwan ML; Yao S; Lee VS; Roh JM; Zhu Q; Ergas IJ; Liu Q; Zhang Y; Kutner SE; Quesenberry CP; Ambrosone CB; Kushi LH

Breast Cancer Res Treat. 2016 Jul 22.

PubMed abstract

A prospective cohort study of early discontinuation of adjuvant chemotherapy in women with breast cancer; the breast cancer quality of care study (BQUAL)

Author(s): Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Buono DL; Nathanson SD; Bovbjerg DH; Mandelblatt JS; Tsai WY; Jacobson JS; Hershman DL

Breast Cancer Res Treat. 2016 Jun 10.

PubMed abstract

Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation; The Breast Cancer Quality of Care (BQUAL) Study

Author(s): Greenlee H; Neugut AI; Falci L; Hillyer GC; Buono D; Mandelblatt JS; Roh JM; Ergas IJ; Kwan ML; Lee M; Tsai WY; Shi Z; Lamerato L; Kushi LH; Hershman DL

JAMA Oncol. 2016 May 12.

PubMed abstract

RE; Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer; CALGB 9741

Author(s): Kwan ML; Quesenberry CP; Caan BJ

J Natl Cancer Inst. 2016 Jan;108(1).

PubMed abstract

Representativeness of breast cancer cases in an integrated health care delivery system

Author(s): Gomez SL; Shariff-Marco S; Von Behren J; Kwan ML; Kroenke CH; Keegan TH; Reynolds P; Kushi LH

BMC Cancer. 2015;15:688. Epub 2015-10-14.

PubMed abstract

The Impact of DNA Input Amount and DNA source on the Performance of Whole-Exome Sequencing in Cancer Epidemiology

Author(s): Zhu Q; Hu Q; Shepherd L; Wang J; Wei L; Morrison CD; Conroy J; Glenn ST; Davis W; Kwan ML; Ergas IJ; Roh JM; Kushi LH; Ambrosone CB; Liu S; Yao S

Cancer Epidemiol Biomarkers Prev. 2015 May 19.

PubMed abstract

Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer

Author(s): Kwan ML; Quesenberry CP; Caan BJ

J Natl Cancer Inst. 2015 Jan;108(1). Epub 2015-11-11.

PubMed abstract

Non-initiation and early discontinuation of adjuvant trastuzumab in women with localized HER2-positive breast cancer

Author(s): Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Leoce N; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Hershman DL

Breast Cancer. 2014 Nov;21(6):780-5. Epub 2014-06-06.

PubMed abstract

Bone health history in breast cancer patients on aromatase inhibitors

Author(s): Kwan ML; Lo JC; Tang L; Laurent CA; Roh JM; Chandra M; Hahn TE; Hong CC; Sucheston-Campbell L; Hershman DL; Quesenberry CP; Ambrosone CB; Kushi LH; Yao S

PLoS ONE. 2014;9(10):e111477. Epub 2014-10-29.

PubMed abstract

Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data

Author(s): Mandelblatt JS; Huang K; Makgoeng SB; Luta G; Song JX; Tallarico M; Roh JM; Munneke JR; Houlston CA; McGuckin ME; Cai L; Clarke Hillyer G; Hershman DL; Neugut AI; Isaacs C; Kushi L

J Oncol Pract. 2014 Aug 26.

PubMed abstract

Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study; a prospective cohort study

Author(s): Greenlee H; Kwan ML; Ergas IJ; Strizich G; Roh JM; Wilson AT; Lee M; Sherman KJ; Ambrosone CB; Hershman DL; Neugut AI; Kushi LH

BMC Cancer. 2014;14:382. Epub 2014-05-29.

PubMed abstract

Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort; Prognostication of short and long term outcomes

Author(s): Caan BJ; Sweeney C; Habel LA; Kwan ML; Kroenke CH; Weltzien EK; Quesenberry CP; Castillo A; Factor RE; Kushi LH; Bernard PS

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):725-34. Epub 2014-02-12.

PubMed abstract

Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort; Differences by age, race, and tumor characteristics

Author(s): Sweeney C; Bernard PS; Factor RE; Kwan ML; Habel LA; Quesenberry CP; Shakespear K; Weltzien EK; Stijleman IJ; Davis CA; Ebbert MT; Castillo A; Kushi LH; Caan BJ

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):714-24. Epub 2014-02-12.

PubMed abstract

Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression

Author(s): Kroenke CH; Sweeney C; Kwan ML; Quesenberry CP; Weltzien EK; Habel LA; Castillo A; Bernard PS; Factor RE; Kushi LH; Caan BJ

Breast Cancer Res Treat. 2014 Apr;144(3):689-99. Epub 2014-03-07.

PubMed abstract

A survey of breast cancer physicians regarding patient involvement in breast cancer treatment decisions

Author(s): Hillyer GC; Hershman DL; Kushi LH; Lamerato L; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Rana S; Neugut AI

Breast. 2013 Aug;22(4):548-54. Epub 2012-10-27.

PubMed abstract

Patient-physician interaction and quality of life in recently diagnosed breast cancer patients

Author(s): Kwan ML; Tam EK; Ergas IJ; Rehkopf DH; Roh JM; Lee MM; Somkin CP; Stewart AL; Kushi LH

Breast Cancer Res Treat. 2013 Jun;139(2):581-95.

PubMed abstract

Employment status and quality of life in recently diagnosed breast cancer survivors

Author(s): Timperi AW; Ergas IJ; Rehkopf DH; Roh JM; Kwan ML; Kushi LH

Psychooncology. 2013 Jun;22(6):1411-20. Epub 2012-08-22.

PubMed abstract

Racial Disparities in Posttraumatic Stress After Diagnosis of Localized Breast Cancer; The BQUAL Study

Author(s): Vin-Raviv N; Hillyer GC; Hershman DL; Galea S; Leoce N; Bovbjerg DH; Kushi LH; Kroenke C; Lamerato L; Ambrosone CB; Valdimorsdottir H; Jandorf L; Mandelblatt JS; Tsai WY; Neugut AI

J Natl Cancer Inst. 2013 Apr 17;105(8):563-72. Epub 2013 Feb 21.

PubMed abstract

Interpersonal influences and attitudes about adjuvant therapy treatment decisions among non-metastatic breast cancer patients: an examination of differences by age and race/ethnicity in the BQUAL study

Author(s): Shelton RC; Clarke Hillyer G; Hershman DL; Leoce N; Bovbjerg DH; Mandelblatt JS; Kushi LH; Lamerato L; Nathanson SD; Ambrosone CB; Neugut AI

Breast Cancer Res Treat. 2013 Feb;137(3):817-28. Epub 2012 Dec 22.

PubMed abstract

Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007

Author(s): Kurian AW; Lichtensztajn DY; Keegan TH; Leung RW; Shema SJ; Hershman DL; Kushi LH; Habel LA; Kolevska T; Caan BJ; Gomez SL

Breast Cancer Res Treat. 2013 Jan;137(1):247-60. Epub 2012 Nov 9.

PubMed abstract

Noninitiation of Adjuvant Chemotherapy in Women With Localized Breast Cancer; The Breast Cancer Quality of Care Study

Author(s): Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Leoce N; Nathanson SD; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Magai C; Tsai WY; Jacobson JS; Hershman DL

J Clin Oncol. 2012 Nov 1;30(31):3800-9. Epub 2012 Sep 24.

PubMed abstract

Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer; The Breast Cancer Quality of Care Study (BQUAL)

Author(s): Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Leoce N; Nathanson SD; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Magai C; Tsai WY; Jacobson JS; Hershman DL

Breast Cancer Res Treat. 2012 Jul;134(1):419-28. Epub 2012 Apr 22.

PubMed abstract

The Breast Cancer Quality of Care Study (BQUAL): A Multi-Center Study to Determine Causes for Noncompliance with Breast Cancer Adjuvant Therapy

Author(s): Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Nathanson SD; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Magai C; Tsai WY; Jacobson JS; Hershman DL

Breast J. 2012 May-Jun;18(3):203-13. Epub 2012 Apr 5.

PubMed abstract

Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer

Author(s): Livaudais JC; Hershman DL; Habel L; Kushi L; Gomez SL; Li CI; Neugut AI; Fehrenbacher L; Thompson B; Coronado GD

Breast Cancer Res Treat. 2012 Jan;131(2):607-17. Epub 2011 Sep 16.

PubMed abstract

Change in physical activity during active treatment in a prospective study of breast cancer survivors

Author(s): Kwan ML; Sternfeld B; Ergas IJ; Timperi AW; Roh JM; Hong CC; Quesenberry CP; Kushi LH

Breast Cancer Res Treat. 2012 Jan;131(2):679-90. Epub 2011 Sep 28.

PubMed abstract

Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment; the Pathways Study

Author(s): Mandelblatt JS; Luta G; Kwan ML; Makgoeng SB; Ergas IJ; Roh JM; Sternfeld B; Adams-Campbell LL; Kushi LH

Breast Cancer Res Treat. 2011 Sep;129(2):521-9. Epub 2011 Apr 8.

PubMed abstract

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer

Author(s): Hershman DL; Shao T; Kushi LH; Buono D; Tsai WY; Fehrenbacher L; Kwan M; Gomez SL; Neugut AI

Breast Cancer Res Treat. 2011 Apr;126(2):529-37. Epub 2010 Aug 28.

PubMed abstract

A practical method for collecting food record data in a prospective cohort study of breast cancer survivors

Author(s): Kwan ML; Kushi LH; Song J; Timperi AW; Boynton AM; Johnson KM; Standley J; Kristal AR

Am J Epidemiol. 2010 Dec 1;172(11):1315-23. Epub 2010 Oct 11.

PubMed abstract

Risk factors for lymphedema in a prospective breast cancer survivorship study; the Pathways Study

Author(s): Kwan ML; Darbinian J; Schmitz KH; Citron R; Partee P; Kutner SE; Kushi LH

Arch Surg. 2010 Nov;145(11):1055-63.

PubMed abstract

Quality of life among women recently diagnosed with invasive breast cancer; the Pathways Study

Author(s): Kwan ML; Ergas IJ; Somkin CP; Quesenberry CP Jr; Neugut AI; Hershman DL; Mandelblatt J; Pelayo MP; Timperi AW; Miles SQ; Kushi LH

Breast Cancer Res Treat. 2010 Sep;123(2):507-24. Epub 2010 Feb 6.

PubMed abstract

Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake

Author(s): Christensen BC; Kelsey KT; Zheng S; Houseman EA; Marsit CJ; Wrensch MR; Wiemels JL; Nelson HH; Karagas MR; Kushi LH; Kwan ML; Wiencke JK

PLoS Genet. 2010 Jul 29;6(7):e1001043.

PubMed abstract

Complementary and alternative therapy use before and after breast cancer diagnosis; the Pathways Study

Author(s): Greenlee H; Kwan ML; Ergas IJ; Sherman KJ; Krathwohl SE; Bonnell C; Lee MM; Kushi LH

Breast Cancer Res Treat. 2009 Oct;117(3):653-65. Epub 2009 Jan 31.

PubMed abstract

Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors

Author(s): Kwan ML; Kushi LH; Weltzien E; Maring B; Kutner SE; Fulton RS; Lee MM; Ambrosone CB; Caan BJ

Breast Cancer Res. 2009;11(3):R31. Epub 2009 May 22.

PubMed abstract

The Pathways Study; a prospective study of breast cancer survivorship within Kaiser Permanente Northern California

Author(s): Kwan ML; Ambrosone CB; Lee MM; Barlow J; Krathwohl SE; Ergas IJ; Ashley CH; Bittner JR; Darbinian J; Stronach K; Caan BJ; Davis W; Kutner SE; Quesenberry CP; Somkin CP; Sternfeld B; Wiencke JK; Zheng S; Kushi LH

Cancer Causes Control. 2008 Dec;19(10):1065-76. Epub 2008 May 14.

PubMed abstract

Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population

Author(s): Caan B; Habel L; Quesenberry C; Kushi L; Herrinton L

J Natl Cancer Inst. 2008 Apr 16;100(8):597-8; author reply 599. Epub 2008 Apr 8.

PubMed abstract